학술논문
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium real world experience
Document Type
Article
Author
Hashmi, H.; Davis, J.; Hansen, D.K.; Peres, L.C.; Puglianini, O.C.; Freeman, C.; De Avila, G.; Locke, F.; Baz, R.; Alsina, M.; Sidana, S.; Shune, L.; McGuirk, J.; Sborov, D.W.; Wagner, C.; Kocoglu, M.H.; Atrash, S.; Voorhees, P.; Simmons, G.; Ferreri, C.; Kalariya, N.; Patel, K.K.; Anderson, L.D.; Afrough, A.; Dima, D.; Khouri, J.
Source
In: Haematologica . (Haematologica, 1 May 2024, 109(5):1514-1524)
Subject
Language
English
ISSN
15928721